China, US Carve Own Paths But Physicians Urge Collaboration With Vaccines Years Away
Global Health Rivalry Or Partnerships?
Despite different approaches, top virologists and renowned front-line physicians from China and the US see the need to share clinical experiences and for global cooperation on treatments and vaccines as economies start re-opening amid fear of a second wave.
You may also be interested in...
Coronavirus Update: Rapid Japan Approval For Remdesivir, Combination With Lilly's Olumiant Is Next Hope
Plus: Chugai enters into Singapore research alliance, Korean consortium reports vaccine progress.
A coronavirus vaccine race is on in China with three domestic developers leading the charge, while traditional medicines are pioneering the drug race after the first official approvals of treatments for COVID-19.
From BeiGene to Innovent to Wuxi Biologics, executives at Chinese pharma firms are now discussing collaborations to go beyond China to become biopharma operations with a truly global presence.